Hikal Limited Announces Q2 Financial Results; Trading Window Set to Reopen on August 9
Hikal Limited announced the unaudited financial results for the quarter ended June 30, 2026, after its Board of Directors meeting held on August 06, 2026. The company released both standalone and consolidated results, along with an unmodified limited review report from its Statutory Auditor.The company's management affirmed that the unaudited financial statements were prepared in accordance with Indian Accounting Standard 34 (Ind AS 34) 'Interim Financial Reporting.' The accompanying statement included a Limited Review Report on the Quarterly Unaudited Standalone and Consolidated Financial Results of the Company.
Key Financial Highlights (Q ended June 30, 2026)
The unaudited financial results for the quarter reflected operational performance across both the standalone and consolidated entities.In terms of total revenue from operations, the figures were reported as follows:
- Standalone: Rs 4,028 million.
- Consolidated: Rs 4,028 million.
Total income for the period stood at Rs 4,046 million across both statements. However, the company recorded a loss in profit for the period: (Rs 75) million on a standalone basis and (Rs 74) million attributable to equity holders of the parent on a consolidated basis.
Segment Performance Analysis
The results show specific performance metrics across the two main segments: Pharmaceuticals and Crop Protection. Both standalone and consolidated segment reporting reflected similar divisional figures for the quarter.For the quarter ended June 30, 2026, the revenue breakdown was:
| Segment | Revenue from Operations (Rs in Millions) |
|---|---|
| Pharmaceuticals | 2,333 |
| Crop Protection | 1,695 |
| Total | 4,028 |
The consolidated segment results showed a total profit/(loss) before tax after exceptional items of (Rs 99) million.
Operational and Trading Update
Regarding corporate governance procedures, the trading window for securities of Hikal Limited was updated. The trading window, which had been closed since July 01, 2026, will re-open on August 09, 2026. However, the special closure of the trading window for Directors, Key Managerial Personnel (KMPs), and specified Senior Management Personnel will remain until otherwise informed by the company.Financial Summary: Q ended June 30, 2026
A summary of the key financial results (in Rs Million) for both the standalone and consolidated statements is provided below:| Metric | Standalone | Consolidated |
|---|---|---|
| Total Revenue from Operations | 4,028 | 4,028 |
| Total Income | 4,046 | 4,046 |
| Profit/(Loss) for the Period | (75) | (74) |
| Total Comprehensive Income/(Loss) | (73) | (72) |
| Basic Earnings Per Share | (0.61) | (0.60) |
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.